http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450199-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2012-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103450199-B |
| titleOfInvention | Theanine modify carboline acyl aminoacid benzyl ester, its preparation, anti-tumor activity and application |
| abstract | The present invention relates to the carboline acyl aminoacid benzyl ester that theanine is modified, its preparation, anti-tumor activity and application, disclose general formula I representative 17 kinds of compounds (in formula, AA is selected from L-Leu, L-Glu, L-Val, L-Trp, L-Pro, L-Tyr, L-Met, L-Phe, L-Ala, L-Gly, L-Asn, L-Asp, L-Ile, L-Lys, L-Ser, L-Theanine residue, or AA-OBzl common designation OBzl), disclose their preparation synthetic method, the present invention further discloses the anti-tumor activity of their inside and outsides, thus the invention discloses their potential applicability in clinical practices as antitumor drug. |
| priorityDate | 2012-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.